Intelligence Platform
Patents
Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9790274
Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastas
granted patentUS 9790233
Compositions and methods of modulating 15-PGDH activity
granted patentUS 9789205
Compositions and methods for gene therapy
granted patentUS 9783550
Highly potent inhibitors of porcupine
granted patentUS 9782464
Methods and compositions for inhibiting diseases of the central nervous system
granted patentUS 9779497
Measuring glomerular number from kidney MRI images
granted patentUS 9770500
S-nitrosylation of glucosylating toxins and uses therefor
granted patentUS 9770504
Generating peptoid vaccines
granted patentUS 9765099
STAT6 inhibitors
granted patentUS 9765027
Substituted 1-arylethyl-4-acylaminopiperidine derivatives as opioid/alpha-adrenoreceptor m
granted patentUS 9757472
Proteas stabilized antibacterial peptides for S. aureus
granted patentUS 9757379
Inhibition of HIF-2Ξ± heterodimerization with HIF1Ξ² (ARNT)
granted patentUS 9750849
Oxygen generating biomaterial
granted patentUS 9751970
Block copolymer and micelle compositions and methods of use thereof
granted patentUS 9744142
Formulations of volatile anesthetics and methods of use for reducing inflammation
granted patentUS 9744235
Treatment of cardiovascular disorders with targeted nanoparticles
granted patentUS 9737512
Methods and compositions for treating chronic pain
granted patentUS 9737527
Biopolymer drug loading method
granted patentUS 9730954
miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of dr
granted patentUS 9731023
Somatostatin receptor-based cancer therapy
granted patentUS 9732114
Compounds having anti-adhesive effects on cancer cells
granted patentUS 9730894
Stabilized HME composition with small drug particles
granted patentUS 9724344
Enhanced delivery of drug compositions to treat life threatening infections
granted patentUS 9725520
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
granted